Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

6. VEXAS, FAST, and PEXIVAS

6. VEXAS, FAST, and PEXIVAS

FromRheumMadness Podcast


6. VEXAS, FAST, and PEXIVAS

FromRheumMadness Podcast

ratings:
Length:
40 minutes
Released:
Jan 26, 2021
Format:
Podcast episode

Description

In this episode we welcome Dr. Didem Saygin, a rheumatology fellow from the University of Chicago, to the podcast.  We are also joined by Dr. Guy Katz, a rheumatology fellow from MGH.  We discuss three more topics that would be excellent teams in the upcoming RheumMadness tournament: the newly discovered VEXAS autoinflammatory syndrome, the FAST trial on cardiovascular safety of urate-lowering therapies, and the PEXIVAS trial in ANCA vasculitis. New RheumMadness website! https://sites.duke.edu/rheummadness/References:VEXAS: https://www.nejm.org/doi/full/10.1056/NEJMoa2026834FAST: https://www.thelancet.com/article/S0140-6736(20)32234-0/fulltextPEXIVAS: https://www.nejm.org/doi/full/10.1056/NEJMoa1803537 RheumMadness Music Attribution: Cheery Monday by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/3495-cheery-mondayLicense: http://creativecommons.org/licenses/by/4.0/
Released:
Jan 26, 2021
Format:
Podcast episode

Titles in the series (32)

The RheumMadness podcast is part of a rheumatology learning initiative sponsored by the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award. Go to https://sites.duke.edu/rheummadness/ to learn more. RheumMadness is created by David Leverenz, MD, who is the recipient of the CSE award. Dr. Leverenz has also received grant funding from Pfizer for quality improvement work unrelated to RheumMadness.